Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in Cancer Diagnostics dealmaking



2.1. Introduction

2.2. Cancer Diagnostics partnering over the years

2.3. Most active Cancer Diagnostics dealmakers

2.4. Cancer Diagnostics partnering by deal type

2.5. Cancer Diagnostics partnering by therapy area

2.6. Deal terms for Cancer Diagnostics partnering

2.6.1 Cancer Diagnostics partnering headline values

2.6.2 Cancer Diagnostics deal upfront payments7

2.6.3 Cancer Diagnostics deal milestone payments

2.6.4 Cancer Diagnostics royalty rates



Chapter 3 – Leading Cancer Diagnostics deals



3.1. Introduction

3.2. Top Cancer Diagnostics deals by value



Chapter 4 – Most active Cancer Diagnostics dealmakers



4.1. Introduction

4.2. Most active Cancer Diagnostics dealmakers

4.3. Most active Cancer Diagnostics partnering company profiles



Chapter 5 – Cancer Diagnostics contracts dealmaking directory



5.1. Introduction

5.2. Cancer Diagnostics contracts dealmaking directory



Chapter 6 – Cancer Diagnostics dealmaking by technology type



Chapter 7 – Partnering resource center



7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking



Appendices



Appendix 1 – Cancer Diagnostics deals by company A-Z



Appendix 2 – Cancer Diagnostics deals by stage of development



Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation



Appendix 3 – Cancer Diagnostics deals by deal type



Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty



Appendix 4 – Cancer Diagnostics deals by therapy area



Appendix 5 –Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from Current Partnering



Table of figures


Figure 1: Cancer Diagnostics partnering since 2014

Figure 2: Active Cancer Diagnostics dealmaking activity since 2014

Figure 3: Cancer Diagnostics partnering by deal type since 2014

Figure 4: Cancer Diagnostics partnering by disease type since 2014

Figure 5: Cancer Diagnostics deals with a headline value

Figure 6: Cancer Diagnostics deals with an upfront value

Figure 7: Cancer Diagnostics deals with a milestone value

Figure 8: Cancer Diagnostics deals with a royalty rate value

Figure 9: Top Cancer Diagnostics deals by value since 2014

Figure 10: Most active Cancer Diagnostics dealmakers since 2014

Figure 11: Online partnering resources

Figure 12: Forthcoming partnering events